Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Submitted by
admin
on September 16, 2014 - 1:42pm
Source:
Yahoo
News Tags:
DeNovo
Eli Lilly
personalized medicine
enzastaurin
Headline:
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Do Not Allow Advertisers to Use My Personal information
